Used primarily in pharmaceutical research, it serves as a key intermediate in the synthesis of bioactive compounds, particularly those targeting neurological disorders. Its structure is leveraged in the development of potential therapeutic agents that modulate neurotransmitter systems. Additionally, it is explored in the design of molecules for studying receptor interactions and signal transduction pathways, aiding in the discovery of new drugs for conditions like depression, anxiety, and chronic pain. Its trifluoromethyl group enhances binding affinity and metabolic stability, making it valuable in medicinal chemistry.